‘Nimesulide’ may come with warning label
New Delhi: Makers of anti-inflammatory drug nimesulide will be required to display cautionary warning labels that the drug be used only as a second-line treatment...
Novo Nordisk to test weight-loss drugs in broader range of obesity-linked conditions
Novo Nordisk plans to examine in clinical trials whether its future weight-loss drugs can treat a wide range of health conditions linked to obesity, as...
Novo Holdings in talks to buy into Surya Hospitals
New Delhi: Novo Holdings, a ₹142 billion investment firm that controls drug maker Novo Nordisk, has entered into exclusive talks to acquire a 49% stake...
India’s heart-risk score in diabetes: Why every Indian must pay attention – A World Heart Month special
India’s diabetes burden is well known, but what’s less visible is the cardiac or heart risk that rides silently alongside it. With cardiovascular disease (heart...
Why Indians skip the flu vaccine despite risks
Every year, as flu season nears, doctors in India urge people to take the quadrivalent influenza vaccine (QIV), a preventive shot offering one-year protection against...
Reckitt has joined hands with PATH-CHRI to Launch Dettol Banega Swasth India – Maternal and Child Health Tech Accelerator.
At a time when India continues to grapple with challenges in maternal and child health outcomes, a new public-private collaboration is aiming to harness technology...
Medicines, medical devices to get cheaper from Sept 22 under new GST regime
The government has directed all pharma companies to revise the MRP of medicines, formulations and medical devices with effect from September 22, 2025 under the...
Roche Pharma partners with 10 govt hospitals to bolster clinical trial capabilities in India
Roche Pharma on Saturday said it has partnered with ten government hospitals to strengthen clinical trial capabilities in India.Under the initiative, nearly 400 professionals have...
Apollo Hospitals to acquire 31 pc stake held by IFC in arm Apollo Health & Lifestyle for Rs 1,254 cr
Healthcare chain Apollo Hospitals Entreprise Ltd on Friday said it will acquire 31 per cent stake held by International Finance Corporation in its arm Apollo...
Why a simple chat with your physician could prevent a diabetes emergency
Living with diabetes isn’t easy. Some days can feel like a constant balancing act. But one of the best tools you have isn’t in a...
Pharma exporters seek rollback of rule banning export of India-only drugs
The new rule by India's drug regulatory authority, which restricts export of pharmaceutical products labelled as "For sale in India only" is causing huge losses...
Cupid announces strategic investment in fragrance brand Mansam
Healthcare products manufacturer Cupid Ltd on Thursday announced that it has signed a term sheet to acquire a strategic stake in Saudi Arabia-based fragrance brand...
Delhi HC stops drug body from taking action against IndiaMart
Mumbai: The Delhi High Court on Tuesday restrained the Central Drugs Standard Control Organisation (CDSCO) from initiating criminal proceedings against online marketplace IndiaMart for allegedly...
WHO adds popular weight-loss drugs to essential medicines list
The World Health Organization (WHO) has added popular weight-loss drugs, including Semaglutide and Tirzepatide, sold in India as Wegovy and Mounjaro respectively, to its Model...
More patients can access key drugs after GST rate cuts
New Delhi: The GST rate cuts announced last week will make medicines used for the treatment of critical conditions like multiple myeloma, lung cancer, blood...
Indian pharma sector needs price hikes, site and IP transfers to tackle US tariff uncertainty: Report
The Indian pharmaceutical industry requires price increases, site and intellectual property (IP) transfers to deal with the prevailing uncertainty in the sector amid US tariffs,...
The missed window: Why half of India’s people with diabetes learn too late
Picture a door representing a healthier, longer life. Initially wide open, it invites you in, but it gradually narrows each year if no action is...
Mankind gets CDSCO nod for Phase 1 clinical trials for molecule to treat autoimmune disorders
Mankind Pharma on Monday said it has received approval from the Central Drugs Standard Control Organisation (CDSCO) to initiate a Phase 1 clinical trial for...
Zydus ties up with Synthon BV for multiple sclerosis drug launch in US
Zydus Lifesciences on Thursday said its subsidiary has joined hands with the Netherlands-based Synthon BV to introduce a generic drug for the treatment of multiple...
Health experts alarmed by GST cut on beedis, demand uniform taxation
Health experts have raised serious concerns over the government's decision to reduce the Goods and Services Tax (GST) on beedis from 28 per cent to...
Glenmark initiates multi-nation Phase 3 clinical trial for lung cancer drug
Glenmark Pharmaceuticals on Friday said it has initiated a multi-country Phase 3 clinical trial for Envafolimab, a novel drug for third-stage non-small cell lung cancer....
AstraZeneca to invest Rs 176 cr to expand GITC in Chennai
Global pharma major AstraZeneca on Saturday announced investment of Rs 176 crore in India to expand capabilities and infrastructure at its Global Innovation & Technology...
USFDA issues Form 483 with 8 observations to Aurobindo’s Telangana unit
Aurobindo Pharma on Friday said the US health regulator has issued a Form 483 with eight observations after inspecting its Telangana-based manufacturing plant.The US Food...
Type 2 diabetes triggering heart attacks in the 30s: Why India’s youth are at risk?
Type 2 diabetes plays a critical role in this growing crisis. In India, where over 77 million people live with diabetes, the condition is increasingly...
Pharma companies cheer lower drug prices, API tax gap stirs worry
Experts in the pharma industry and med-tech sectors hailed the GST reforms, noting that these will lower costs of medicines for patients, ease working capital...
GST cut on drugs, medical devices to provide relief to patients: Industry players
New Delhi, The government's move to cut GST on medicines and medical devices while exempting lifesaving drugs from the levy is a bold step that...
Alkem’s Enzene powers into US with $70 m investment
Mumbai: Enzene Biosciences, the fast-emerging biotech subsidiary of Alkem Labs, which is among the top five pharmaceutical companies in India, has launched a new manufacturing...
Medical device manufacturers allowed to give free samples
New Delhi: Manufactures of medical devices are permitted to provide free evaluation samples to the doctors to acquire hands-on experience in using the product, provided...
CCI clears Manipal Hospitals’ proposal to acquire Sahyadri Hospitals
Competition watchdog CCI on Tuesday cleared healthcare major Manipal Hospitals' proposal to acquire Pune-based Sahyadri Hospitals from global investor Ontario Teachers' Pension Plan Board in...
Fortis Healthcare arm inks 15-year lease with RR Lifesciences to expand NCR reach
Fortis Healthcare Limited today said that its wholly owned subsidiary, International Hospital Limited (IHL), has entered into a 15-year lease agreement with RR Lifesciences Limited...
The #WeightofDiabetes iceberg: Why the real burden lies beneath the surface
If you picture diabetes as an iceberg, the part visible above water represents those living with diagnosed diabetes: the people checking their blood sugar, taking...
Pharmaceutical industry seeks relief from rate inversion
New Delhi: The pharmaceutical industry may get relief on the long-standing issue of Goods and Services Tax (GST) inversion, with recent discussions between companies and...
Indian hospitals battle central line infections linked to mismanagement of tubes used for administering medicines and fluids
A seven-year study, covering a total of 54 private and public hospitals and 200 ICUs in India, has revealed that over 8,600 cases of severe...
Welcure Drugs & Pharmaceuticals board approves bonus and stock split
Welcure Drugs & Pharmaceuticals on Monday said its board has approved proposals for a bonus issue of shares and stock split to enhance liquidity and...
Scientists find why ultra-processed diets make you gain fat even without extra calories: Study
An international team of scientists has now discovered that people gain more weight on an ultra-processed diet compared to a minimally processed diet, even when...
Murae Organisor plans to boost agro-sector presence under Rs 80-cr investment strategy
Pharmaceutical firm Murae Organisor said it is evaluating a structured plan to strengthen its agro-sector presence through R&D and infrastructure-led initiatives with an investment of...
Zydus Saroglitazar shows positive Phase 3 results in rare liver disease PBC, US filing planned in 2026
Zydus Therapeutics, the US-based innovation-focused specialty arm of Zydus Lifesciences, has announced promising results from a late-stage clinical trial of its experimental drug Saroglitazar. The...
Dr Reddy’s launches novel drug for chronic constipation management
Dr Reddy's Laboratories on Tuesday said it has launched a first-in-class generic medication for chronic constipation in the country. The drug firm has launched Linaclotide,...
IHH Healthcare to add 2,000 beds in India by 2028
Multinational healthcare provider IHH Healthcare on Thursday said it plans to add around 2,000 new beds in India by 2028 as it unveiled a new...
FDA approves updated COVID-19 shots but limits access for some kids and adults
U.S. regulators approved updated COVID-19 shots Wednesday but limited their use for many Americans - and removed one of the two vaccines available for young...
Catching heart disease in its quietest moments in Type 2 diabetes
Imagine if we could detect heart disease in its earliest, quietest moments in Type 2 diabetes, before it even has a chance to trigger a...
Drug, medtech companies fear GST changes may squeeze funds
New Delhi: The pharmaceutical and medtech industries are worried about the impending Goods and Services Tax (GST) reforms as they expect the step to impact...
Dr Reddy’s expects new GST framework to address critical issues impacting pharma sector
Dr Reddy's Laboratories on Tuesday expressed hope that the new GST structure will take care of existing challenges and aid in ushering a rationalised, industry-friendly...
Pharmexcil seeks aligning GST rates on formulations, APIs
Pharmaceuticals Export Promotion Council of India (Pharmexcil) has sought alignment of GST rates on both active pharmaceutical ingredients and formulations to reduce complexity and enhance...
GSK re-enters India’s cancer drug market
GlaxoSmithKline Pharmaceuticals is re-entering India’s oncology market with the launch of Jemperli (dostarlimab) and Zejula (niraparib)— precision therapies indicated in the treatment of certain gynaecological...
Substantial cancer drugs beyond ambit of current price control mechanisms: Parliamentary panel
A Parliamentary panel has flagged that a substantial segment of cancer drugs are still beyond the ambit of current price control mechanisms and recommended measures...
Expand AYUSH-based services to promote integrative oncology approaches: Parliamentary panel
A parliamentary committee has recommended taking proactive steps to expand the institutional footprint of AYUSH-based healthcare services across the country to promote integrative oncology approaches...
India’s healthcare chains set their hearts on foreign patients
Mumbai: India’s healthcare providers are vying for a greater share of overseas patients amid a surge in foreign tourists arriving in the country for medical...
Global PE firms tighten grip on India’s $80-billion hospital sector
India’s private hospital industry has undergone a major ownership shift over the last five years, moving steadily into the hands of global private equity firms,...
IMA warns of misuse, mis-prescription of new weight-loss drugs, such as Wegovy and Mounjaro
The Indian Medical Association (IMA) has sounded a warning bell on the potential misuse and mis-prescription of weight-loss drugs, such as Wegovy and Mounjaro.These GLP-1...
Novo Nordisk warns patients after theft of weight-loss, diabetes drugs
Novo Nordisk today said that urge people to buy Novo Nordisk medications only from authorised pharmacies, accompanied by a valid prescription and invoice, a day...
CDSCO issues alert on Novo drugs after reported theft
New Delhi: The Central Drugs Standard Control Organization (CDSCO) has issued an alert to healthcare professionals to be careful in prescribing Novo Nordisk products after...
Welcure Drugs & Pharma to set up agro-pharma lab for around Rs 80 crore
Welcure Drugs & Pharmaceuticals Ltd on Wednesday said it will set up an agro-pharma research laboratory with an investment of Rs 70-80 crore for the...
Natco Pharma sues Novo Nordisk in generic drug push
MUMBAI: Hyderabad-based Natco Pharma has sued Danish drugmaker Novo Nordisk, maker of blockbuster weight-loss drug Wegovy (semaglutide), claiming its version of the drug does not...
Four new drugs for rare diseases on anvil; five medications for 7 ailments in market: VK Paul
Four new drugs for rare diseases are in the pipeline expected to be launched soon while five medications for seven illnesses have already been introduced...
Aurobindo Pharma closing in on $5.5b Zentiva buyout
Mumbai: Aurobindo Pharma has emerged as the frontrunner to acquire Prague-based generic drugmaker Zentiva for $5-5.5 billion (Rs 43,500-47,900 crore) from Advent International, said several...
Alembic gets USFDA nod for generic drug for skin condition
Alembic Pharmaceuticals on Monday said it has received approval from the US health regulator to market a generic medication to treat acne vulgaris in the...
Indian drugmakers seek exemption for generics from US supplies probe
Mumbai: A US government probe into pharmaceutical imports and their implications on national security must exclude generic drugs from its purview, a business delegation from...
Glenmark, Alembic Pharma, Sun Pharma recall products in US: USFDA
Drug makers Glenmark, Alembic Pharmaceuticals and Sun Pharma are recalling products in the US due to manufacturing issues, according to the US health regulator. Mumbai-based...
Zydus Lifesciences gets USFDA approval for angina, high blood pressure drug
Zydus Lifesciences on Monday said it has received approval from the US health regulator to market a drug used to treat angina and high blood...
Aurobindo Pharma expects China plant to break even at EBITDA level this year
New Delhi: Aurobindo Pharma expects its China facility to break even in the third quarter of the current financial year, according to its CFO Santhanam...
Food Chained: How weight-loss drugs are changing India’s eating habits and forcing restaurants to take note
Rakesh Goyal, a businessman in East Delhi, can’t bear to look at chhole-bhature any longer. It was his favourite food, the Sunday lunch he looked...
Welcure Drugs & Pharma board to consider share split, bonus issue this month
New Delhi: Welcure Drugs & Pharmaceuticals on Monday said its board will meet on August 22 to consider a proposal of division of equity shares...
Asia Healthcare Holdings to invest Rs 400 crore in Asian Institute of Nephrology and Urology to double hospital network
Asia Healthcare Holdings, a leading healthcare investment platform backed by Singapore’s GIC and TPG, will invest Rs 400 crore in Asian Institute of Nephrology and...
Intas Pharma completes acquisition of UDENYCA biosimilar for $558 million
Intas Pharma has completed the acquisition of UDENYCA for $558 million, the company said in a release.UDENYCA is a biosimilar to Neulasta or Pegfilgrastim. It...
From burden to breakthrough: Reimagining the #WeightofDiabetes through meaningful conversations with your doctor
Managing type 2 diabetes is not just a clinical task; it’s a deeply personal journey. Beyond blood sugar checks and medication, it involves navigating weight...
Eli Lilly launches Mounjaro KwikPen for diabetes, obesity treatment in India
US pharmaceutical major Eli Lilly on Wednesday launched its blockbuster diabetes drug Mounjaro in KwikPen, a single patient use prefilled pen designed for once weekly...
Max Healthcare to nearly double capacity to 9,500 beds by 2028 after strong quarterly growth
Max Healthcare Institute, India’s largest healthcare chain by market cap, plans to nearly double its bed capacity to 9,500 in the next three years, Abhay...
Cohance Lifesciences announces $10 million investment in US-based arm
Cohance Lifesciences on Tuesday announced a strategic investment of USD 10 million (around Rs 87.6 crore) to expand bioconjugation capabilities at its US-based subsidiary, NJ...
Chemists seek ban on quick commerce sale of prescription drugs
The All India Organisation of Chemists and Druggists (AIOCD) has written to Union Home Minister Amit Shah seeking urgent action to curb the online sale...
Lupin ties up with Sandoz to commercialise biosimilar product
Drug firm Lupin on Tuesday said it has partnered with Switzerland-based Sandoz Group AG to commercialise its biosimilar ranibizumab across multiple regions.Under the terms of...
India clears Roche’s 7-minute cancer injection Tecentriq for patients, with Phase IV trial condition
New Delhi: The technical committee constituted for supervising clinical trials on new chemical entities has cleared Swiss drug major Roche to import and market cancer...
Pfizer launches next-gen vaccine for pneumococcal disease
Drug firm Pfizer on Monday said it has launched its next-generation 20-valent pneumococcal conjugate vaccine (PCV20) for adults in India. The vaccine helps protect against...
Welcure Drugs & Pharmaceuticals posts Rs 23.29 crore profit for Apr-Jun quarter
Welcure Drugs & Pharmaceuticals on Tuesday reported a net profit of Rs 23.29 crore for the April-June quarter of FY2025-26, driven by strong order flow.The...
Executive order by US administration excludes Pharma sector from immediate tariff imposition: Indian Pharmaceutical Alliance
The Indian pharmaceutical sector has been "excluded" from the immediate US tariff imposition, as generic medicines are "important" for affordable healthcare in the United States,...
Biocon sees GLP-1 weight-loss therapy as a future growth driver
Biocon will continue to deepen its push in the insulin business, even as the biopharmaceutical company will have GLP-1 weight-loss therapy as one of the...
Managing diabetes in a country obsessed with quick fixes: A scientific perspective
In societies that prioritise rapid solutions, diabetes management presents a significant challenge for both patients and healthcare providers. Many individuals resist routine blood glucose monitoring...
Govt gives BIS exemption to parts used in medical devices for now
In a major relief to the medical devices industry, the ministry of steel has agreed to put in abeyance its notification that said raw materials...
Weight-loss drug Mounjaro crosses Rs 100 crore sales in 4 months
US drugmaker Eli Lilly's weight-loss drug Mounjaro (tirzepatide) has crossed Rs 100 crore in sales in India in just four months of launch, making it...
Medical device firms sound the alarm over new steel standards
Confusion over the ministry of steel's latest mandate could fuel shortages of surgical blades, needles, endoscopes and other medical products in the coming days, industry...
Novo Nordisk’s Wegovy, Mounjaro sales in India double on month in July
Sales of Danish drugmaker Novo Nordisk's Wegovy and U.S. rival Eli Lilly's Mounjaro in India doubled in July from a month earlier, data from research...
Indian pharma on alert as US mulls higher drug tariffs
Indian drug makers are weighing the possible fallout of additional reciprocal tariffs imposed by the US in response to the country's oil purchases from Russia....
More heart attacks in diabetes? Here’s what you should know
If you have type 2 diabetes (T2D), you might have heard about how it can affect your heart. Yes, it's true, people with diabetes are...
Indian generics wave next year set to sink obesity drug price
As several leading Indian drugmakers are readying to launch the generic versions of Danish drug maker Novo Nordisk’s blockbuster weight-loss drug semaglutide in March next...
Pharma tariffs may go as high as 250%, says Trump
US President Donald Trump said Tuesday that upcoming tariffs on imported pharmaceuticals could go as high as 250 percent -- after starting at a lower...
Discussing the #WeightofDiabetes with your Doctor
If you’re living with type 2 diabetes (T2D), obesity, or both, you’re not alone. Millions are on this journey too. However, here’s something many overlook:...
Mind, muscle, and metabolism: The power of holistic diabetes management
When you think about diabetes, what’s the first thing that comes to mind? Chances are, you thought of blood sugar levels. And yes, that’s an...
Corner Office Conversation with The New Leaders of Indian Pharma – The Economic Times Video
India’s pharma sector is at a turning point transitioning from a global generics powerhouse to a serious contender in biotech and innovation. In this episode,...
Manipal Hospitals seeks CCI nod to acquire Sahyadri Hospitals for about Rs 6,400 cr
Healthcare major Manipal Hospitals has sought approval from the fair trade regulator CCI to acquire Pune-based Sahyadri Hospitals from global investor Ontario Teachers' Pension Plan...
Pvt hospitals line up Rs 32k crore capex to add 14.5k beds by FY27: Report
Eleven listed hospital chains and two major unlisted players are expected to add around 14,500 beds by FY2027, entailing capital expenditure of around Rs 32,000...
Sun Pharmaceutical says it won’t expand US manufacturing base amid tariff concerns
India’s largest drug maker Sun Pharmaceutical has no plans to further expand its manufacturing base in the US even as potential reciprocal tariff remains a...
Healthcare costs in US to shoot up following Trump tariff on Indian goods: Industry experts
New Delhi: Healthcare costs in the US will increase following the imposition of sweeping 25 per cent tariff plus an unspecified penalty on Indian goods,...
70% enrolment of participants for Phase III clinical trial of dengue vaccine completed: Centre
Seventy percent enrolment of participants for the Phase III clinical trial of the indigenous one-shot dengue vaccine, DengiAll, has been completed, Minister of State for...
Apollo entities seek CCI nod for recast plan
Apollo Group entities have sought the Competition Commission of India's (CCI) approval for a composite restructuring plan that would eventually lead to the separate listing...
Pharma major Eli Lilly claims its weight loss drug reduces cardiovascular risks in Type 2 diabetes patients
Pharma major Eli Lilly today said that it’s weight loss drug Mounjaro has helped in reducing cardiovascular risks in patients with Type 2 diabetes and...
Obesity drugs gain weight in labs: Several clinical trials by big and small pharma cos underway
Mumbai: As blockbuster weight-loss drugs Wegovy (semaglutide) and Mounjaro (tirzepatide) reap billions of dollars on hysteric demand for innovators Novo Nordisk and Eli Lilly, more...
650 private hospitals in Haryana to withdraw from Ayushman Bharat scheme over unpaid dues
In a massive blow to beneficiaries of the Ayushman Bharat health scheme, around 650 private hospitals across Haryana are set to stop providing treatment under...
PE funds vie for a majority stake in medical devices maker Sensa Core
Mumbai: KKR, TPG, Kedaara Capital, and Multiples Alternate Asset Management are among homegrown and global private equity firms in early-stage discussions to acquire a majority...
Understanding the chain reaction of chronic diseases
Have you ever heard the saying, “When it rains, it pours”? That is what happens with chronic health conditions like diabetes, obesity, high blood pressure,...
Torrent Pharmaceuticals plans Semaglutide rollout post patent expiry
Mumbai: Torrent Pharmaceuticals is planning to catch the first wave of semaglutide launch once Danish drugmaker Novo Nordisk's patent expires early next year. The Ahmedabad-based...
Women vs Men: 7 key ways weight loss works differently
Weight loss isn’t one-size-fits-all. From metabolism and muscle mass to hormones and fat storage, here are 7 key differences in how men and women lose...
Homegrown cell, gene therapy pioneer ImmunoACT turns profitable in first year of ops
India’s cell and gene therapy pioneer ImmunoAct has turned profitable in its first full year of operations, a rare feat in the country’s emerging startup...
Does green coffee really help you lose weight? Here’s the truth – What is Green Coffee?
While green coffee offers benefits like improved metabolism and reduced fat absorption, its effects are mild on their own. For noticeable and sustainable weight loss,...
Non-alcoholic fatty liver disease: An acute menace and a silent killer
Fatty liver disease was once considered a relatively rare and benign condition. It now has become one of the most pressing public health concerns. The...
Cipla targets $1 bn US revenue in FY27
Mumbai: Cipla aims to achieve $1 billion sales in the US by the next fiscal year, driven by the products it has lined up for...
Experts flag UK-India FTA over patent terms, access to drugs
Mumbai: Experts in intellectual property law and civil society groups in India have raised concerns that provisions in the UK-India Free Trade Agreement, Comprehensive Economic...
ICMR study found Covid vaccination didn’t raise risk of unexplained sudden deaths among young adults: J P Nadda
An ICMR study has found that Covid vaccination did not increase the risk of unexplained sudden deaths among young adults in India, Union Health Minister...
Duty relief to boost pharma companies’ access to UK drug stores
The India-UK FTA is expected to give a strong tailwind to India's pharmaceutical and medical devices sectors with tariff relief and smoother regulatory pathways acting...
India-UK FTA: Zero duty to boost India’s generic drug, medical device exports to Britain
Exports of generic medicines and medical devices like X-ray systems and surgical instruments will get a boost as Britian has agreed upon zero duty under...
7,000 steps a day may be the new magic number for better health: Lancet Study
Walking at least 7,000 steps a day can yield significant health benefits, according to a study published in The Lancet Public Health journal this week.It...
Natco Pharma offers to acquire nearly 36% stake in Adcock Ingram in Rs 2,100-cr deal
Natco Pharma on Wednesday said it has offered to acquire nearly 36 per cent stake in South African drug firm Adcock Ingram Holdings for up...
Civil society organisations urge govt to scrap animal testing in biosimilar development
New Delhi: Civil society organisations have approached the health ministry, seeking to remove animal studies to speed up biosimilar development.In their representation to the government,...
PLI scheme for bulk drugs led to import savings of Rs 1,362 cr: Govt
Imports of pharma raw materials worth Rs 1,362 crore have been avoided till March 2025 due to the creation of domestic manufacturing capacity for 25...
ADIA signs a definitive agreement to invest $200 million in medical devices firm Meril
Abu Dhabi Investment Authority (ADIA) has signed a definitive agreement to invest $200 million (about Rs1,725 crore) for a 3% stake in medical devices maker...
Abu Dhabi Investment Authority to buy 3% stake in Micro Life Sciences for $200 mn
Abu Dhabi Investment Authority on Monday said it will acquire a 3 per cent stake in medical devices firm Micro Life Sciences Pvt Ltd (Meril)...
Brookfield, EQT close in on Gland Pharma, but rising stock a pain
MUMBAI: Buyout groups Brookfield and EQT are in active discussions to buy Hyderabad-based Gland Pharma, a contract development and manufacturing organisation (CDMO) and injectables company,...
Dr Reddy’s gets seven observations from USFDA for Andhra plant
Dr Reddy's Laboratories has received a Form 483 with seven observations from the US health regulator for its Srikakulam-based plant in Andhra Pradesh, according to...
New dilemma looms for India’s private hospitals: More beds, but few can lie in them
There is a new dichotomy looming on the horizon for India’s private hospitals.Capacity expansion lined up by top players and recent record investments and blockbuster...
Central drugs laboratories find 55 samples to be ‘not of standard quality’ in June
The central drugs laboratories have found 55 samples manufactured by various firms in June to be "not of standard quality", health ministry officials said on...
Sprays, pills, creams…ooh, aah, ouch? India’s pain market is now a Rs 16,000 cr giant
Mumbai: Indians are increasingly popping over-the-counter pills, using sprays or rubbing in creams to soothe their aches and pains, adding more than a billion dollars...
Kenvue ties up with API to launch India’s first Cough Clinics
Kenvue, a consumer health company and makers of Benadryl cough syrup, on Friday announced the launch of 'Cough Clinics', an industry-first initiative, in association with...
ET Graphics: Weight loss drugs Tirzepatide, Semaglutide dominate India, misuse fears rise
New-age weight-loss molecules have taken over the anti-obesity drug market in India, with tirzepatide and semaglutide (generic names) collectively occupying 75% of the market share....
Aurobindo to produce, supply long acting HIV treatment drug
New Delhi: Aurobindo Pharma on Tuesday said it will manufacture and supply the long-acting injectable HIV treatment cabotegravir across 133 countries. The Hyderabad-based drugmaker has...
Marengo Hospitals lines up ₹150 cr for western foray
New Delhi: Multi specialty hospital platform Marengo Asia Healthcare plans to soon foray into Maharashtra and Rajasthan with an investment of ₹150 crore as part...
Aayush Wellness expands nutraceutical product portfolio
Aayush Wellness on Monday announced the expansion of its nutraceutical product portfolio with the launch of a capsule to support cognitive function and memory retention....
Cipla eyes entry into India’s weight management market amid rising demand and global competition
Drug major Cipla is preparing to foray into the weight management segment in India, its MD and global CEO Umang Vohra has said.The Mumbai-based firm...
Phase-3 clinical trial enrolment for India’s first dengue vaccine to be completed by October: ICMR
Enrolment of about 10,500 participants in the phase III clinical trial of the indigenous one-shot Panacea Biotec developed dengue vaccine, DengiAll, is likely to be...
India pharma, healthcare revenue to grow steadily in Q1FY26E; EBITDA margins under pressure: Report
Indian pharma and healthcare sector will witness steady revenue growth in the first quarter of the Financial Year 2026 (Q1FY26E), but concerns loom as EBITDA...
India’s Ayush ‘innovations’ featured in WHO’s brief on AI in traditional medicine
The WHO has acknowledged India's efforts in integrating Artificial Intelligence (AI) with traditional medicine systems, particularly Ayush systems, the Centre said on Saturday. The World...
Wockhardt exits US generics biz to focus on drug discovery
Mumbai: Wockhardt will exit its loss-making generics business in the US as part of its strategy to enhance focus on innovation with new antibiotic drug...
Adani to create world-class, affordable, AI-first healthcare ecosystems
Billionaire Gautam Adani on Friday revealed plans to build an AI-first, multidisciplinary healthcare ecosystem that integrates affordability, scalability, and global best practices, as he shared...
PGIMER doctors perform India’s first robot-assisted vasovasostomy
The Postgraduate Institute of Medical Education and Research (PGIMER) here on Thursday said that a team of its doctors from the urology department have successfully...
Ontario Teachers’ announces major India healthcare deal, to sell Sahyadri Hospitals to Manipal Hospitals
The Ontario Teachers’ Pension Plan Board (Ontario Teachers’) announced on July 9 its decision to sell its majority stake in Sahyadri Hospitals Group to Manipal...
Manipal Health buys Sahyadri Hospitals for Rs 6,400 crore
Manipal Health Enterprises, India's 2nd largest hospital chain, has bought Sahyadri Hospitals from Canada’s Ontario Teachers Pension Plan (OTPP), as per an official release from...
Max Healthcare, Aston University partner for advanced academic, research cooperation
Max Healthcare on Wednesday said it has partnered with Aston University, UK, to establish advanced academic and research cooperation in healthcare, medical sciences, and allied...
Pharma lobby flags ‘cumbersome’ export rule, seeks change
New Delhi: A significant dip in exports has prompted pharma lobby groups to raise a demand for changing the centralised no-object certification (NOC) provision for...
Nectar to sell API, formulations & menthol biz to Ceph Lifesciences for Rs 1,290 cr
Nectar Lifesciences Ltd on Tuesday said it will sell its active pharmaceutical ingredients and formulation along with menthol business assets to Ceph Lifesciences Pvt Ltd,...
Sun Pharma says working towards full regulatory resolution at 3 plants facing USFDA action
Drug major Sun Pharmaceutical Industries aims to bolster compliance across its manufacturing operations and work towards achieving full regulatory resolution at the three facilities facing...
Biocon Biologics gets UK MHRA nod for biosimilars Vevzuo, Evfraxy
Biocon Ltd on Monday said its arm Biocon Biologics Ltd has received marketing authorisations from the Medicines and Healthcare products Regulatory Agency (MHRA) in the...
DRDO, AIIMS-Rishikesh ink MoU for clinical trials in field of biomedical devices
An institute of the DRDO has signed an agreement with AIIMS, Rishikesh for conducting "clinical trials" and advanced research in the field of biomedical devices...
Union Health Minister JP Nadda, Delhi CM Rekha Gupta flag off Ayushman Bharat registration vans in New Delhi
Union Minister of Health and Family Welfare JP Nadda and Delhi Chief Minister Rekha Gupta flagged off Ayushman Bharat registration vans in Vigyan Bhavan in...
No link between Covid-19, vaccine and heart attacks: Karnataka expert panel
There is no association between premature cardiovascular disease in a patient and a prior history of Covid-19 infection or Covid vaccination, an expert committee tasked...
Lupin launches Ipratropium Bromide nasal spray in US
Pharma major Lupin Ltd on Friday said it has launched Ipratropium Bromide nasal spray, used in treatment of runny nose, in the US market. The...
Niti to review concerns over pharma quality
New Delhi: Growing quality concerns in the pharmaceutical industry has prompted government's think tank Niti Aayog to step in. It has called industry experts to...
CBI searches premises of Pharmacy Council of India chief in corruption case
The CBI has conducted searches at the premises of Pharmacy Council of India (PCI) President Montu M Patel after he was booked for alleged corruption...
Torrent Pharma to acquire additional 2.41% stake in JB Chemicals for Rs 620 crore
Ahmedabad-based drug maker Torrent Pharmaceuticals Torrent Pharmaceuticals Ltd has signed a share purchase agreement to acquire an additional 2.41% stake in J.B. Chemicals & Pharmaceuticals...
Karnataka CM’s remarks on covid vaccines ‘factually incorrect,’ says Biocon chief Kiran Mazumdar-Shaw
Biocon founder Kiran Mazumdar-Shaw on Thursday opposed Karnataka Chief Minister Siddaramaiah's remarks linking covid-19 vaccines with a spate of heart attack deaths in the state's...
Covid-19 jabs don’t raise risk of sudden death: ICMR-NIE Director
New Delhi: Covid-19 vaccines did not increase the risk of sudden death among young adults in India, Manoj Murhekar, director, ICMR-National Institute of Epidemiology reiterated,...
Biocon eyes Canadian bonanza from generics of weight-loss ‘super-drugs’ Ozempic and Wegovy
Biocon Ltd. plans to file for regulatory approvals of generic versions of Novo Nordisk A/S’s Ozempic and Wegovy in key markets as it races to...
Welcure Drugs & Pharma secures export orders worth Rs 86 crore
Welcure Drugs & Pharmaceuticals on Tuesday said it has bagged two export orders worth Rs 85.6 crore from Giant Exim and Ravina International. On June...
Young and fit dropping dead: A sector comes into focus
The recent death of Shefali Jariwala, best known for the 2002 chartbuster ‘Kaanta Laga’, due to cardiac arrest, has again brought to light the increasing...
After a robust march, pharma exports slow
New Delhi: India's pharmaceuticals exports grew only 1.5% year-on-year in April and May after an impressive 31.2% jump in March when companies expedited shipments to...
Torrent expects JB Chemicals acquisition deal to close in 15–18 months
Torrent Pharmaceuticals expects to complete its proposed acquisition of a majority stake in Mumbai-based J B Chemicals and Pharmaceuticals within the next 15 to 18...
Clear & Legible: Labelling on drug packets to get a booster
Do you find it difficult to read the details on a medicine strip, with the surface being too glossy and shiny. Here's a good news....
Torrent, JB Chemicals finalising steps for two-stage merger, combine may find place in pharma big 5
Torrent Pharmaceuticals and JB Chemicals & Pharmaceuticals are working with advisers to firm up the terms for their merger as part of a two-stage transaction,...
Aurobindo Pharma recalls 4,608 bottles of pain relieving drug in US
Aurobindo Pharma is recalling over 4,600 bottles of a pain relieving drug in the US market due to manufacturing issues, according to the US health...
Torrent Pharma closes in on JB Chem likely for $2.4 bn buyout, eyes $1.6 billion financing
Torrent Pharma is in advanced discussions with private equity group KKR to buy JB Chemicals and Pharmaceuticals, almost 10 months after their initial discussions fell...
Tata Memorial Centre to provide affordable high-dose MIBG therapy for neuroblastoma
Mumbai: A high-dose MIBG (metaiodobenzylguanidine) therapy for treating neuroblastoma, a type of cancer mostly found in children, will be provided at an affordable cost of...
Biocon drops plan to launch weight-loss drugs in China, executive says
Indian drugmaker Biocon has abandoned plans to market generic versions of Novo Nordisk's hot-selling diabetes and weight-loss drugs in China due to local competition, a...
Plans to restrict open market access to tuberculosis medicines
With cases of drug-resistant tuberculosis on the rise in India, authorities are set to tighten open market access to newer anti-TB drugs Bedaquiline and Delamanid,...
Eli Lilly to launch Mounjaro KwikPen for type 2 diabetes in India
US pharmaceutical major Eli Lilly on Thursday announced plans to launch its blockbuster diabetes drug Mounjaro in KwikPen, a single patient use prefilled pen designed...
Bharat Biotech, GSK to slash malaria vaccine price
Bharat Biotech and GSK have decided to progressively reduce the price of their malaria vaccine by more than half to less than $5 per dose...
Lupin gets USFDA nod for generic chronic constipation treatment drug
Pharma major Lupin Ltd on Wednesday said it has received approval from the US health regulator for its generic version of Prucalopride tablets indicated for...
Weight-loss drug Wegovy starts at ₹17,345 in India
Mumbai: Wegovy (semaglutide), the popular weight-loss drug from Danish drug maker Novo Nordisk, is priced between '17,345 and '26,015 across dosages in India. The company...
Novo Nordisk aims for heavy sales in India with Wegovy
MUMBAI: Danish drug giant Novo Nordisk is aiming to hit $1 billion (Rs 8,600 crore) sales in India with its blockbuster weight-loss drug Wegovy (semaglutide)...
Sickle cell anaemia test kits priced less than Rs 50 in govt’s bid to eradicate the disease
Sickle cell anaemia tests have become much more affordable, with the government driving the prices of kits to less than Rs 50 in its bid...
ICMR’s NIIH develops simple point of care test for haemophilia A, Von Willebrand Disease
A simple and affordable point-of-care test kit has been indigenously developed by the National Institute of Immunohaematology for early diagnosis of genetic bleeding disorders haemophilia...
A new HIV drug promises 99.9% protection. But it’s making Indian health activists wary; Why?
The US Food and Drug Administration (FDA) has approved lenacapavir, a new injectable drug that claims to offer 99.9% protection against HIV. But concerns are...
From pimples to peptides: How Gen Z turned the dermatologist into a beauty guru
Dermatology clinics are the new beauty salons.Consumers in urban India are no longer walking into a dermat’s office with just eczema, psoriasis or some other...
Eli Lilly says its anti-obesity pill matches Ozempic
New Delhi: Eli Lilly said on Saturday that its anti-obesity pill, Orforglipron, has shown significant results during clinical trials in reducing weight and lowering blood...
The Wegovy effect: A weight-loss drug reshapes the lives of teens battling obesity
High-school freshman Austin Smith sank into depression from the merciless teasing and bullying he endured from his classmates over his weight. By age 15, Katie...
Stress at work? Doctors see rise in heart diseases among young executives
Bengaluru | New Delhi: For 31-year-old techie Kumar, long hours at work carrying well into the night often led to stress eating, coupled with an...
US approves Gilead’s twice-yearly injection to prevent HIV
The US Food and Drug Administration on Wednesday approved Gilead Sciences' twice-yearly injection to prevent HIV -- a move the company hailed as a major...
USFDA issues Form 483 with 7 observations to Natco’s pharma Hyderabad division
Natco Pharma on Thursday said the US health regulator has issued a Form 483 with seven observations after inspecting its pharma division in Hyderabad.The US...
Welcure Drugs & Pharmaceuticals signs Rs 517 crore supply mandate with Thailand firm
Welcure Drugs & Pharmaceuticals on Wednesday said it has executed a definitive mandate for third-party sourcing and procurement services aggregating to Rs 517 crore with...
With no upgradation plan, several small drug companies may shut operations
New Delhi: Thousands of pharmaceutical companies in the micro, small and medium enterprise (MSME) sector face the grim prospect of closure, having passed the May-end...
Suraksha Diagnostics to invest Rs 200 cr to set up over 20 centres across east India
Suraksha Diagnostics on Wednesday said it will invest Rs 200 crore to set up over 20 advanced imaging centres across eastern India.The plan, which will...
Torrent Pharma keen to break into big league
Ahmedabad-based Torrent Pharma is revving up for acquisitions in India as part of its plans to break into the top three drugmakers over a span...
70% vaccines sourced by WHO, 14% generics imported by US are from India: Minister
Union Minister of State for Health Anupriya Patel said on Monday 70 per cent of total vaccines sourced by the World Health Organization (WHO) and...
US pharma bets big on China to snap up potential blockbuster drugs
U.S. drugmakers are licensing molecules from China for potential new medicines at an accelerating pace, according to new data, betting they can turn upfront payments...
Lupin inks pact with China’s Sino Universal Pharmaceuticals for Tiotropium dry powder inhaler
Pharma major Lupin Ltd on Monday said it has signed a license and supply agreement with China's Sino Universal Pharmaceuticals for the commercialisation of Tiotropium...
Manipal, Fortis in talks to raise Rs 5,000 cr for Sahyadri Hospitals bid
With the bidding deadline for Sahyadri Hospitals approaching on June 22, interested bidders including Manipal Health Enterprises and Fortis Healthcare are engaging with foreign lenders...
Sun Pharma gets eight observations from USFDA for Halol plant
Drug major Sun Pharma on Saturday said the US health regulator has issued a Form 483 with 8 observations after inspecting its Halol (Gujarat) manufacturing...
Kirti Ganorkar: Why the veteran insider is the right dose for Sun Pharma
Mumbai: For nearly thirty years, Kirti Ganorkar quietly stood at Sun Pharma as a rock, much like his astute boss Dilip Shanghvi, the founder of...
Sun Pharma appoints Kirti Ganorkar as MD; Dilip Shanghvi to continue as the Executive Chairman of the Board
Sun Pharmaceutical Industries has appointed Kirti Ganorkar as the Managing Director to succeed Dilip Shanghvi, effective September 1, with the entire business and all functions...
Delhi HC refuses to halt Sun Pharma’s Pruease tables sales over trademark row
The Delhi High Court has refused to restrain Sun Pharmaceutical Industries and its wholly-owned subsidiary Sun Pharma Laboratories from selling Pruease tablets, used for constipation...
Niti Aayog may prescribe major revamp of AIIMS Delhi
The Niti Aayog is likely to suggest a major revamp of the All-India Institute of Medical Sciences (AIIMS), Delhi, including a significant expansion to enable...
Bharat Biotech, GSK join hands to develop vaccine for severe diarrhoea
Bharat Biotech on Thursday said it has partnered with GSK plc for the development of a vaccine for Shigellosis, a severe form of bacterial diarrhoea.The...
Diagnostic chains plan to scale up as Covid cases surge
New Delhi: Leading diagnostic chains are looking to scale up their operations amid surging Covid-19 cases in the country. Executives said they were seeing a...
UAE based Shaiva Group, Taranis Capital to invest Rs 2,125 Cr in Telangana
UAE-based companies Shaiva Group and Taranis Capital have committed to invest Rs 2,125 crore in Telangana, the state government said on Tuesday. State Minister for...
Pharma body opposes entry curbs on medical representatives, seeks rethink
New Delhi: The Indian Pharmaceutical Alliance (IPA), IPA, a lobby group which represents large domestic pharmaceutical companies, has raised concerns over the government's recent mandate...
Indian pharma firms not copying products, India respect IP rights, says Goyal
Dismissing allegations that Indian pharmaceutical companies copy products of Swiss firms, Commerce and Industry Minister Piyush Goyal on Tuesday said it is a long-standing myth...
Single speciality hospitals boom on strong demand, PE infusion
Mumbai: India's market for single-speciality hospitals is set to more than double to $31 billion in three-four years from the current $15 billion, amid their...
Regulator set to monitor antimicrobial resistance
New Delhi: India's drug regulatory authority has joined hands with the Department of Animal Husbandry and Dairying (DAHD) and the Ministry of Fisheries to address...
Advent International to acquire stake in Felix Pharmaceuticals
Advent International, a leading global private equity investor, signed a definitive agreement to invest $175 million via primary and secondary for a significant minority stake...
KKR-backed IVI to buy ART Fertility Clinics for $450 million
KKR-backed IVI RMA Global, a US-based leader in infertility treatment, is set to acquire ART Fertility Clinics for $400-450 million, according to people familiar with...
Weight-loss drug bulks up sales as patients upgrade dosage
Mumbai: Sales of Mounjaro, Eli Lilly’s blockbuster weight-loss and diabetes drug, have touched Rs 24 crore within three months of its India launch, making it...
IIT Delhi and AIIMS Delhi to establish AI centre for healthcare with Rs 330 crore grant
New Delhi: With a focus on developing AI-based solutions that support key national health programmes in the country, IIT Delhi and AIIMS Delhi signed a...
Murae Organisor board to consider bonus issue, dividend payout next week
Pharmaceuticals company Murae Organisor on Tuesday said its board will meet on June 13 to consider a bonus issue of equity shares and dividend payment...
Wockhardt eyes USD 7 billion market opportunity for antibiotic Zaynich in US, Europe
Drugmaker Wockhardt on Friday said its novel antibiotic Zaynich has an addressable market opportunity of USD 7 billion in the US and Europe. The company...
